Short Interest in BIO-key International Inc. (NASDAQ:BKYI) Declines By 27.8%

BIO-key International Inc. (NASDAQ:BKYI) was the target of a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 224,434 shares, a drop of 27.8% from the February 12th total of 310,850 shares. Currently, 2.2% of the shares of the company are short sold. Based on an average daily volume of 275,973 shares, the short-interest ratio is presently 0.8 days. Based on an average daily volume of 275,973 shares, the short-interest ratio is presently 0.8 days. Currently, 2.2% of the shares of the company are short sold.

BIO-key International Price Performance

NASDAQ:BKYI traded down $0.01 during trading hours on Friday, reaching $0.65. 123,447 shares of the company were exchanged, compared to its average volume of 550,306. The business has a 50 day moving average of $0.62 and a 200 day moving average of $0.71. BIO-key International has a 1-year low of $0.51 and a 1-year high of $1.97. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.26 and a quick ratio of 1.13. The company has a market capitalization of $7.03 million, a P/E ratio of -0.62 and a beta of 0.41.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on BKYI. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a report on Wednesday, January 21st. Wall Street Zen raised BIO-key International to a “sell” rating in a report on Saturday, January 3rd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

Institutional Investors Weigh In On BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC boosted its position in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the period. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 26.51% of the company’s stock.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.